189 Trademark Results found for "lag*"

Also try searching for:

*lag

Details	Status	Class/Description
LAGERE OLALEYE FALURO 2070705 12 Dec 2020	REGISTERED on 30 Aug 2023	Computer keyboards; computer mice Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Computer keyboards; computer mice
LAGOM MIKE ANDERSON 2064466 17 Nov 2020	REGISTERED on 14 Dec 2022	Legal assistance in the drawing up of contracts; legal consultancy on ... Class 045 Class 045 Personal & Legal & Social Services Legal assistance in the drawing up of contracts; legal consultancy on the topics of television advertising, television entertainment and sports; legal consultancy relating to intellectual property rights; legal document preparation services
lagoped LAGOPED 2073566 5 Nov 2020	REGISTERED on 20 Dec 2024	Cuir; peaux d'animaux; malles et valises; parapluies et parasols; cann... Class 018 Class 018 Leather Products not including clothing Cuir; peaux d'animaux; malles et valises; parapluies et parasols; cannes; fouets; sellerie; portefeuilles; porte-monnaie; porte-cartes de crédit [portefeuilles]; colliers pour animaux; habits pour animaux de compagnie; sacs, à savoir sacs à dos, sacs à dos d'alpinisme, sacs à dos de sport, sacs à dos de randonnée, sacs de randonnée, sacs pour vêtements de sport; coffrets destinés à contenir des articles de toilette dits « vanity cases », à savoir sacs pour articles de toilette vendus vides, sacs à lessive pour le transport des articles de toilette, sacs vides pour articles de rasage, coffrets pour articles de toilette vendus vides. Class 022 Class 022 Ropes, Cordage and Fiber Products Cordes; ficelles; tentes; bâches; voiles (gréement); matières de rembourrage (à l'exception du caoutchouc ou des matières plastiques), à savoir fibres de rembourrage, ouate de rembourrage, laine de rembourrage, plumes pour le rembourrage, paille pour le rembourrage; fibres textiles à l'état brut; fibres textiles non travaillées; fibres textiles; sacs de grande contenance pour le transport et l'entreposage de matériaux en vrac; sacs (enveloppes, pochettes) en matières textiles pour l'emballage. ... Class 025 Clothing Products Vêtements, à savoir vêtements de sport, vêtements d'exercice; chaussures, à savoir chaussures de randonnée, chaussures de montagne, chaussures de marche; chapellerie; chemises; vêtements en cuir, à savoir vêtements de sport en cuir; ceintures (habillement); gants (habillement); foulards; cravates; bonneterie; chaussettes; chaussons; chaussures de plage; chaussures de ski; chaussures de sport; sous-vêtements.
LAGDURITY BRISTOL-MYERS SQUIBB COMPANY 2057274 14 Oct 2020	REGISTERED on 29 Dec 2023	Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.
LAGOPDI BRISTOL-MYERS SQUIBB COMPANY 2054828 30 Sept 2020	REGISTERED on 19 Feb 2024	Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as antiinfectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.
LAGLOTOK BRISTOL-MYERS SQUIBB COMPANY 2054860 30 Sept 2020	REGISTERED on 19 Feb 2024	Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as antiinfectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.
LAGIMMU BRISTOL-MYERS SQUIBB COMPANY 2054864 30 Sept 2020	REGISTERED on 19 Feb 2024	Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as antiinfectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.
LAGENIO SHENZHEN LAGENIO TECHNOLOGY CO. LTD 2052395 17 Sept 2020	REGISTERED on 22 Feb 2023	Cases for smartphones; computer mouse pads; covers for tablet computer... Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Cases for smartphones; computer mouse pads; covers for tablet computers; earphones; mobile phone chargers; mobile phones; multi-outlet socket blocks; notebook computers; smartwatches; stands adapted for mobile phones; tablet computers; USB cables; wireless headsets for smartphones; wristwatches featuring a cellphone and display screen for viewing, sending and recording text messages and emails
LAGOON HEXO OPERATIONS INC. 2047417 24 Aug 2020	SEARCHED on 9 Aug 2024	Dried cannabis; cannabis extracts and concentrates in the form of hash... Class 034 Class 034 Smoker's Products Dried cannabis; cannabis extracts and concentrates in the form of hash, kief, oils, waxes, shatter; prefilled cartridges of cannabis oil for oral vaporizors
LAGFFSSUN & DESIGN LIHONG JIA 2038051 6 Jul 2020	REGISTERED on 14 Jun 2023	Body protectors for American football; body protectors for sports use;... Class 028 Class 028 Toys and Sporting Goods Products Body protectors for American football; body protectors for sports use; chest expanders; elbow guards for sports use; elbow pads for American football; flippers for diving; focus pads for martial arts; ice hockey pucks; ice skates; knee guards for sports use; leg guards for sports use; masquerade masks; nets for sports; protective padding for playing sports; skipping ropes; snow skis; swimming kickboards; swimming webs; tennis nets

REGISTERED

on 30 Aug 2023

LAGERE

OLALEYE FALURO

2070705 · 12 Dec 2020

009

Computer keyboards; computer mice

REGISTERED

on 14 Dec 2022

LAGOM

MIKE ANDERSON

2064466 · 17 Nov 2020

045

Legal assistance in the drawing up of contracts; legal consultancy on ...

REGISTERED

on 20 Dec 2024

lagoped

LAGOPED

2073566 · 5 Nov 2020

018

022

...

Cuir; peaux d'animaux; malles et valises; parapluies et parasols; cann...

REGISTERED

on 29 Dec 2023

LAGDURITY

BRISTOL-MYERS SQUIBB COMPANY

2057274 · 14 Oct 2020

005

Class 005

Pharmaceutical Products

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.

Pharmaceutical preparations for human use for the treatment and preven...

REGISTERED

on 19 Feb 2024

LAGOPDI

BRISTOL-MYERS SQUIBB COMPANY

2054828 · 30 Sept 2020

005

Class 005

Pharmaceutical Products

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as antiinfectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.

Pharmaceutical preparations for human use for the treatment and preven...

REGISTERED

on 19 Feb 2024

LAGLOTOK

BRISTOL-MYERS SQUIBB COMPANY

2054860 · 30 Sept 2020

005

Class 005

Pharmaceutical Products

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as antiinfectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.

Pharmaceutical preparations for human use for the treatment and preven...

REGISTERED

on 19 Feb 2024

LAGIMMU

BRISTOL-MYERS SQUIBB COMPANY

2054864 · 30 Sept 2020

005

Class 005

Pharmaceutical Products

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as antiinfectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.

Pharmaceutical preparations for human use for the treatment and preven...

REGISTERED

on 22 Feb 2023

LAGENIO

SHENZHEN LAGENIO TECHNOLOGY CO. LTD

2052395 · 17 Sept 2020

009

Cases for smartphones; computer mouse pads; covers for tablet computer...

SEARCHED

on 9 Aug 2024

LAGOON

HEXO OPERATIONS INC.

2047417 · 24 Aug 2020

034

Dried cannabis; cannabis extracts and concentrates in the form of hash...

REGISTERED

on 14 Jun 2023

LAGFFSSUN & DESIGN

LIHONG JIA

2038051 · 6 Jul 2020

028

Body protectors for American football; body protectors for sports use;...

Owners

Lagostina s.P.A. (11)

Lagunitas brewing company (9)

Bristol-myers squibb company (4)

Construction navale bordeaux (3)

International paints (canada) limited (3)

Lagom clinics inc. (3)

Aston martin lagonda limited (2)

Kl north america b.V. (2)

Lagardere sca (2)

Lagatia corp. (2)

Categories

Class 9 (31)

Class 35 (28)

Class 21 (23)

Class 25 (22)

Class 5 (20)

Class 11 (20)

Class 32 (19)

Class 30 (17)

Class 3 (16)

Class 33 (16)

Class 41 (16)

Class 7 (15)

Class 16 (15)

Class 12 (13)

Class 28 (13)

Class 29 (13)

Class 37 (12)

Class 8 (10)

Class 14 (10)

Class 20 (10)

Class 42 (10)

Class 18 (9)

Class 1 (7)

Class 2 (7)

Class 19 (7)

Class 40 (7)

Class 43 (7)

Class 44 (7)

Class 24 (6)

Class 38 (6)

Class 22 (5)

Class 34 (5)

Class 36 (5)

Class 39 (5)

Class 6 (4)

Class 45 (4)

Class 17 (3)

Class 10 (2)

Class 26 (2)

Class 27 (2)

Class 31 (2)

Class 4 (1)

Class 15 (1)

Correspondents

Smart & biggar lp (26)

Borden ladner gervais llp (14)

Robic agence pi s.E.C./ robic ip agency lp (14)

Gowling wlg (canada) llp (12)

Moffat & co. (10)

Fasken martineau dumoulin llp (8)

Drapeaulex inc. (7)

Marks & clerk (5)

Lavery, de billy, llp (4)

Display

List View

Grid View

Apply for Trademark

Select countries to protect your logo trademark

Trademark Name

Country Selected

Canada

$599 / 1 class + gov fee

United States

$99 / 1 class + gov fee

Canada

$599 / 1 class + gov fee

Mexico

$499 / 1 class + gov fee

European Union

$700 / 1 class + gov fee

China

$499 / 1 class + gov fee

South Korea

$699 / 1 class + gov fee

Japan

$799 / 1 class + gov fee

India

$99 / 1 class + gov fee

United Kingdom

$499 / 1 class + gov fee

Australia

$299 / 1 class + gov fee

Israel

$699 / 1 class + gov fee

United Arab Emirates

$699 / 1 class + gov fee

New Zealand

$699 / 1 class + gov fee

Brazil

$499 / 1 class + gov fee

Taiwan

$799 / 1 class + gov fee

Ukraine

$799 / 1 class + gov fee

Indonesia

$699 / 1 class + gov fee

South Africa

$499 / 1 class + gov fee

Singapore

$799 / 1 class + gov fee

Saudi Arabia

$799 / 1 class + gov fee

Afghanistan

$799 / 1 class + gov fee

Algeria

$799 / 1 class + gov fee

Argentina

$399 / 1 class + gov fee

Austria

$899 / 1 class + gov fee

Bahrain

$699 / 1 class + gov fee

Bangladesh

$599 / 1 class + gov fee

Benelux

$999 / 1 class + gov fee

Bhutan

$899 / 1 class + gov fee

Bolivia

$799 / 1 class + gov fee

Botswana

$1299 / 1 class + gov fee

British Virgin Islands

$1199 / 1 class + gov fee

Bulgaria

$799 / 1 class + gov fee

Cambodia

$799 / 1 class + gov fee

Chile

$499 / 1 class + gov fee

Colombia

$699 / 1 class + gov fee

Congo

$1199 / 1 class + gov fee

Costa Rica

$899 / 1 class + gov fee

Croatia

$899 / 1 class + gov fee

Cyprus

$999 / 1 class + gov fee

Czech Republic

$899 / 1 class + gov fee

Denmark

$799 / 1 class + gov fee

Dominican Republic

$899 / 1 class + gov fee

Ecuador

$799 / 1 class + gov fee

Egypt

$699 / 1 class + gov fee

El Salvador

$799 / 1 class + gov fee

Ethiopia

$1099 / 1 class + gov fee

France

$899 / 1 class + gov fee

Gaza

$799 / 1 class + gov fee

Germany

$899 / 1 class + gov fee

Greece

$799 / 1 class + gov fee

Guatemala

$899 / 1 class + gov fee

Haiti

$899 / 1 class + gov fee

Honduras

$899 / 1 class + gov fee

Hong Kong (SAR)

$899 / 1 class + gov fee

Hungary

$1099 / 1 class + gov fee

Iraq

$1499 / 1 class + gov fee

Italy

$899 / 1 class + gov fee

Jordan

$799 / 1 class + gov fee

Kazakhstan

$799 / 1 class + gov fee

Kenya

$899 / 1 class + gov fee

Kuwait

$799 / 1 class + gov fee

Laos

$699 / 1 class + gov fee

Lebanon

$999 / 1 class + gov fee

Lesotho

$1199 / 1 class + gov fee

Libya

$899 / 1 class + gov fee

Madrid Protocol (WIPO)

$1999 / 1 class + gov fee

Malawi

$1099 / 1 class + gov fee

Malaysia

$699 / 1 class + gov fee

Maldives

$999 / 1 class + gov fee

Morocco

$999 / 1 class + gov fee

Mozambique

$899 / 1 class + gov fee

Myanmar

$799 / 1 class + gov fee

Namibia

$799 / 1 class + gov fee

Nepal

$699 / 1 class + gov fee

Nicaragua

$899 / 1 class + gov fee

Norway

$899 / 1 class + gov fee

Oman

$1099 / 1 class + gov fee

Pakistan

$799 / 1 class + gov fee

Panama

$899 / 1 class + gov fee

Paraguay

$899 / 1 class + gov fee

Peru

$799 / 1 class + gov fee

Philippines

$899 / 1 class + gov fee

Poland

$499 / 1 class + gov fee

Portugal

$899 / 1 class + gov fee

Puerto Rico

$899 / 1 class + gov fee

Qatar

$799 / 1 class + gov fee

Romania

$899 / 1 class + gov fee

Serbia

$899 / 1 class + gov fee

Slovakia

$899 / 1 class + gov fee

Spain

$899 / 1 class + gov fee

Sri Lanka

$699 / 1 class + gov fee

Swaziland

$1299 / 1 class + gov fee

Sweden

$799 / 1 class + gov fee

Switzerland

$899 / 1 class + gov fee

Thailand

$799 / 1 class + gov fee

Tunisia

$899 / 1 class + gov fee

Turkey

$799 / 1 class + gov fee

Uganda

$699 / 1 class + gov fee

United Republic of Tanzania

$699 / 1 class + gov fee

Uruguay

$799 / 1 class + gov fee

Venezuela

$899 / 1 class + gov fee

Vietnam

$799 / 1 class + gov fee

West Bank, Palestine

$799 / 1 class + gov fee

Yemen

$1699 / 1 class + gov fee

Albania

$899 / 1 class + gov fee

Andorra

$899 / 1 class + gov fee

Angola

$1299 / 1 class + gov fee

Antigua and Barbuda

$1299 / 1 class + gov fee

Armenia

$799 / 1 class + gov fee

Azerbaijan

$799 / 1 class + gov fee

Bahamas

$1399 / 1 class + gov fee

Barbados

$1299 / 1 class + gov fee

Belgium

$999 / 1 class + gov fee

Belize

$1299 / 1 class + gov fee

Benin

$799 / 1 class + gov fee

Bosnia and Herzegovina

$999 / 1 class + gov fee

Brunei

$1299 / 1 class + gov fee

Burkina Faso

$799 / 1 class + gov fee

Burundi

$1199 / 1 class + gov fee

Cabo Verde

$899 / 1 class + gov fee

Cameroon

$799 / 1 class + gov fee

Central African Republic (CAR)

$799 / 1 class + gov fee

Chad

$799 / 1 class + gov fee

Comoros

$799 / 1 class + gov fee

Cote d'Ivoire

$799 / 1 class + gov fee

Czechia

$999 / 1 class + gov fee

Djibouti

$1199 / 1 class + gov fee

Dominica

$1299 / 1 class + gov fee

Equatorial Guinea

$799 / 1 class + gov fee

Eritrea

$999 / 1 class + gov fee

Estonia

$1299 / 1 class + gov fee

Eswatini

$1299 / 1 class + gov fee

Fiji

$899 / 1 class + gov fee

Finland

$699 / 1 class + gov fee

Gabon

$799 / 1 class + gov fee

Gambia

$899 / 1 class + gov fee

Georgia

$799 / 1 class + gov fee

Ghana

$999 / 1 class + gov fee

Grenada

$1299 / 1 class + gov fee

Guinea

$799 / 1 class + gov fee

Guinea-Bissau

$799 / 1 class + gov fee

Guyana

$1299 / 1 class + gov fee

Iceland

$1299 / 1 class + gov fee

Ireland

$899 / 1 class + gov fee

Jamaica

$1199 / 1 class + gov fee

Kiribati

$999 / 1 class + gov fee

Kosovo

$899 / 1 class + gov fee

Kyrgyzstan

$899 / 1 class + gov fee

Latvia

$699 / 1 class + gov fee

Liberia

$999 / 1 class + gov fee

Liechtenstein

$999 / 1 class + gov fee

Lithuania

$699 / 1 class + gov fee

Luxembourg

$999 / 1 class + gov fee

Madagascar

$999 / 1 class + gov fee

Mali

$799 / 1 class + gov fee

Malta

$599 / 1 class + gov fee

Marshall Islands

$999 / 1 class + gov fee

Mauritania

$799 / 1 class + gov fee

Mauritius

$999 / 1 class + gov fee

Micronesia

$999 / 1 class + gov fee

Moldova

$999 / 1 class + gov fee

Monaco

$1399 / 1 class + gov fee

Mongolia

$599 / 1 class + gov fee

Montenegro

$899 / 1 class + gov fee

Nauru

$999 / 1 class + gov fee

Netherlands

$999 / 1 class + gov fee

Niger

$799 / 1 class + gov fee

Nigeria

$399 / 1 class + gov fee

North Macedonia

$899 / 1 class + gov fee

Palau

$999 / 1 class + gov fee

Palestine

$999 / 1 class + gov fee

Papua New Guinea

$799 / 1 class + gov fee

Rwanda

$999 / 1 class + gov fee

Saint Kitts and Nevis

$1299 / 1 class + gov fee

Saint Lucia

$1299 / 1 class + gov fee

Saint Vincent and the Grenadines

$1299 / 1 class + gov fee

Samoa

$1199 / 1 class + gov fee

San Marino

$999 / 1 class + gov fee

Sao Tome and Principe

$999 / 1 class + gov fee

Senegal

$799 / 1 class + gov fee

Seychelles

$999 / 1 class + gov fee

Sierra Leone

$999 / 1 class + gov fee

Slovenia

$899 / 1 class + gov fee

Solomon Islands

$999 / 1 class + gov fee

Somalia

$999 / 1 class + gov fee

South Sudan

$999 / 1 class + gov fee

Suriname

$1599 / 1 class + gov fee

Tajikistan

$799 / 1 class + gov fee

Tanzania

$699 / 1 class + gov fee

Timor-Leste

$999 / 1 class + gov fee

Togo

$799 / 1 class + gov fee

Tonga

$1299 / 1 class + gov fee

Trinidad and Tobago

$1399 / 1 class + gov fee

Turkmenistan

$799 / 1 class + gov fee

Tuvalu

$999 / 1 class + gov fee

Uzbekistan

$699 / 1 class + gov fee

Vanuatu

$1199 / 1 class + gov fee

Zambia

$899 / 1 class + gov fee

Zimbabwe

$899 / 1 class + gov fee

OAPI

$899 / 1 class + gov fee

ARIPO

$999 / 1 class + gov fee

Page 4 of 19